Atrial fibrillation/flutter and Glomerulosclerosis

Summary:

Glomerulosclerosis is found among people with Atrial fibrillation/flutter, especially for people who are male, 60+ old.

The study analyzes which people have Glomerulosclerosis with Atrial fibrillation/flutter. It is created by eHealthMe based on reports of 11 people who have Atrial fibrillation/flutter from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,362 drugs and 3,844 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

What is Glomerulosclerosis?

Glomerulosclerosis (a hardening of the glomerulus in the kidney) is found to be associated with 148 drugs and 198 conditions by eHealthMe. Check the latest studies of Glomerulosclerosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11 people who have Atrial Fibrillation/Flutter and Glomerulosclerosis are studied.

Would you have Glomerulosclerosis when you have Atrial fibrillation/flutter?

Gender of people who have Atrial Fibrillation/Flutter and experienced Glomerulosclerosis *:

female: 10 %
male: 90 %

Age of people who have Atrial Fibrillation/Flutter and experienced Glomerulosclerosis *:

Common co-existing conditions for these people *:

Localised Infection (infection at the single location): 3 people, 27.27%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
Optic Neuritis (optic nerve inflammation): 1 person, 9.09%
Jock Itch (fungal infection of the groin and upper thighs): 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%
Infection: 1 person, 9.09%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
Hiv Infection: 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Herpes Simplex (herpes simplex is a common viral infection): 1 person, 9.09%

Common drugs taken by these people *:

Amlodipine: 3 people, 27.27%
Pradaxa: 3 people, 27.27%
Vitamin D: 2 people, 18.18%
Sodium Bicarbonate: 1 person, 9.09%
Duoneb: 1 person, 9.09%
Aspirin: 1 person, 9.09%
Augmentin '125': 1 person, 9.09%
Betamethasone Dipropionate: 1 person, 9.09%
Biktarvy: 1 person, 9.09%
Ciclopirox: 1 person, 9.09%

Common symptoms for these people *:

Rashes (redness): 6 people, 54.55%
Hyperkalemia (damage to or disease of the kidney): 5 people, 45.45%
Pulmonary Oedema (fluid accumulation in the lungs): 5 people, 45.45%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 36.36%
Weight Increased: 4 people, 36.36%
Haematuria (presence of blood in urine): 4 people, 36.36%
Glomerulonephritis Rapidly Progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function): 4 people, 36.36%
Septic Shock (shock due to blood infection): 4 people, 36.36%
Glomerular Filtration Rate Decreased: 4 people, 36.36%
Oedema (fluid collection in tissue): 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Glomerulosclerosis?

- Check whether Glomerulosclerosis is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Glomerulosclerosis and Atrial fibrillation/flutter, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.